Financhill
Sell
43

TMO Quote, Financials, Valuation and Earnings

Last price:
$402.63
Seasonality move :
4.39%
Day range:
$397.32 - $405.44
52-week range:
$390.50 - $627.88
Dividend yield:
0.4%
P/E ratio:
23.63x
P/S ratio:
3.59x
P/B ratio:
3.08x
Volume:
2.5M
Avg. volume:
2.8M
1-year change:
-28.42%
Market cap:
$152.1B
Revenue:
$42.9B
EPS (TTM):
$17.05
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $32.2B $39.2B $44.9B $42.9B $42.9B
Revenue Growth (YoY) 26.14% 21.71% 14.55% -4.58% 0.05%
 
Cost of Revenues $16.2B $19.6B $25.9B $25.8B $25.2B
Gross Profit $16B $19.6B $19B $17.1B $17.7B
Gross Profit Margin 49.67% 50.08% 42.24% 39.9% 41.28%
 
R&D Expenses $1.2B $1.4B $1.5B $1.3B $1.4B
Selling, General & Admin $6.9B $8B $9B $8.4B $8.6B
Other Inc / (Exp) -$175M -$891M -$218M -$524M -$367M
Operating Expenses $8.1B $9.4B $10.5B $9.8B $10B
Operating Income $7.9B $10.2B $8.5B $7.3B $7.7B
 
Net Interest Expenses $488M $493M $454M $496M $312M
EBT. Incl. Unusual Items $7.2B $8.8B $7.8B $6.3B $7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $850M $1.1B $703M $284M $657M
Net Income to Company $6.4B $7.7B $7B $6B $6.3B
 
Minority Interest in Earnings -$2M -$3M -$10M $40M -$3M
Net Income to Common Excl Extra Items $6.4B $7.7B $7B $6B $6.3B
 
Basic EPS (Cont. Ops) $16.09 $19.62 $17.75 $15.52 $16.58
Diluted EPS (Cont. Ops) $15.96 $19.46 $17.63 $15.45 $16.53
Weighted Average Basic Share $396M $394M $392M $386M $382M
Weighted Average Diluted Share $399M $397M $394M $388M $383M
 
EBITDA $10.1B $12B $11.9B $11.1B $11.5B
EBIT $7.8B $9.4B $8.6B $7.7B $8.4B
 
Revenue (Reported) $32.2B $39.2B $44.9B $42.9B $42.9B
Operating Income (Reported) $7.9B $10.2B $8.5B $7.3B $7.7B
Operating Income (Adjusted) $7.8B $9.4B $8.6B $7.7B $8.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $9.9B $11.8B $10.7B $10.3B $10.4B
Revenue Growth (YoY) 59.01% 19.3% -9.38% -3.41% 0.18%
 
Cost of Revenues $4.7B $6.4B $6.6B $6.1B $6.1B
Gross Profit $5.2B $5.5B $4.1B $4.2B $4.2B
Gross Profit Margin 52.58% 46.24% 38.66% 40.65% 40.86%
 
R&D Expenses $320M $364M $346M $331M $342M
Selling, General & Admin $1.8B $2.3B $2.1B $2.2B $2.1B
Other Inc / (Exp) -$197M -$165M -$158M -$19M -$95M
Operating Expenses $2.1B $2.6B $2.5B $2.5B $2.4B
Operating Income $3.1B $2.8B $1.7B $1.7B $1.8B
 
Net Interest Expenses $113M $118M $154M $84M $100M
EBT. Incl. Unusual Items $2.8B $2.5B $1.4B $1.6B $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $416M $301M $46M $281M $95M
Net Income to Company $2.3B $2.2B $1.3B $1.3B $1.5B
 
Minority Interest in Earnings -- -$5M -$3M -$4M -$4M
Net Income to Common Excl Extra Items $2.3B $2.2B $1.3B $1.3B $1.5B
 
Basic EPS (Cont. Ops) $5.93 $5.66 $3.34 $3.47 $3.99
Diluted EPS (Cont. Ops) $5.88 $5.61 $3.32 $3.46 $3.98
Weighted Average Basic Share $394M $392M $386M $382M $378M
Weighted Average Diluted Share $397M $395M $388M $384M $379M
 
EBITDA $3.5B $3.5B $2.5B $2.8B $2.6B
EBIT $2.9B $2.7B $1.7B $2B $1.9B
 
Revenue (Reported) $9.9B $11.8B $10.7B $10.3B $10.4B
Operating Income (Reported) $3.1B $2.8B $1.7B $1.7B $1.8B
Operating Income (Adjusted) $2.9B $2.7B $1.7B $2B $1.9B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $35.9B $41.1B $43.8B $42.5B $42.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $17.4B $21.2B $26.2B $25.3B $25.2B
Gross Profit $18.5B $19.9B $17.6B $17.2B $17.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.3B $1.5B $1.5B $1.3B $1.4B
Selling, General & Admin $7.2B $8.5B $8.8B $8.5B $8.5B
Other Inc / (Exp) -$346M -$859M -$211M -$385M -$442M
Operating Expenses $8.5B $9.9B $10.3B $9.8B $9.9B
Operating Income $10B $10B $7.4B $7.3B $7.8B
 
Net Interest Expenses $511M $498M $490M $426M $328M
EBT. Incl. Unusual Items $9.2B $8.6B $6.7B $6.5B $7.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2B $994M $448M $519M $472M
Net Income to Company $7.9B $7.6B $6B $6B $6.5B
 
Minority Interest in Earnings -- -$8M -$8M $39M -$4M
Net Income to Common Excl Extra Items $7.9B $7.6B $6B $6B $6.5B
 
Basic EPS (Cont. Ops) $20.03 $19.34 $15.44 $15.66 $17.09
Diluted EPS (Cont. Ops) $19.86 $19.18 $15.34 $15.59 $17.05
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $12.1B $12B $10.9B $11.3B $11.4B
EBIT $9.7B $9.2B $7.5B $8B $8.4B
 
Revenue (Reported) $35.9B $41.1B $43.8B $42.5B $42.9B
Operating Income (Reported) $10B $10B $7.4B $7.3B $7.8B
Operating Income (Adjusted) $9.7B $9.2B $7.5B $8B $8.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $9.9B $11.8B $10.7B $10.3B $10.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.7B $6.4B $6.6B $6.1B $6.1B
Gross Profit $5.2B $5.5B $4.1B $4.2B $4.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $320M $364M $346M $331M $342M
Selling, General & Admin $1.8B $2.3B $2.1B $2.2B $2.1B
Other Inc / (Exp) -$197M -$165M -$158M -$19M -$95M
Operating Expenses $2.1B $2.6B $2.5B $2.5B $2.4B
Operating Income $3.1B $2.8B $1.7B $1.7B $1.8B
 
Net Interest Expenses $113M $118M $154M $84M $100M
EBT. Incl. Unusual Items $2.8B $2.5B $1.4B $1.6B $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $416M $301M $46M $281M $95M
Net Income to Company $2.3B $2.2B $1.3B $1.3B $1.5B
 
Minority Interest in Earnings -- -$5M -$3M -$4M -$4M
Net Income to Common Excl Extra Items $2.3B $2.2B $1.3B $1.3B $1.5B
 
Basic EPS (Cont. Ops) $5.93 $5.66 $3.34 $3.47 $3.99
Diluted EPS (Cont. Ops) $5.88 $5.61 $3.32 $3.46 $3.98
Weighted Average Basic Share $394M $392M $386M $382M $378M
Weighted Average Diluted Share $397M $395M $388M $384M $379M
 
EBITDA $3.5B $3.5B $2.5B $2.8B $2.6B
EBIT $2.9B $2.7B $1.7B $2B $1.9B
 
Revenue (Reported) $9.9B $11.8B $10.7B $10.3B $10.4B
Operating Income (Reported) $3.1B $2.8B $1.7B $1.7B $1.8B
Operating Income (Adjusted) $2.9B $2.7B $1.7B $2B $1.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $10.3B $4.5B $8.5B $8.1B $4B
Short Term Investments -- -- -- $3M $1.6B
Accounts Receivable, Net $5.7B $8B $8.1B $8.2B $8.2B
Inventory $4B $5.1B $5.6B $5.1B $5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.1B $1.6B $1.6B $1.8B $2B
Total Current Assets $22B $20.1B $25.2B $24.6B $22.1B
 
Property Plant And Equipment $5.9B $8.3B $9.3B $9.4B $9.3B
Long-Term Investments -- -- -- -- --
Goodwill $26B $41.9B $41.2B $44B $45.9B
Other Intangibles $12.7B $20.1B $17.4B $16.7B $15.5B
Other Long-Term Assets $2.5B $4.6B $4B $4B $4.5B
Total Assets $69.1B $95.1B $97.2B $98.7B $97.3B
 
Accounts Payable $2.2B $2.9B $3.4B $2.9B $3.1B
Accrued Expenses $4.2B $5.4B $5.4B $4.8B $5.2B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- $11.1B
Total Current Liabilities $10.3B $13.4B $17B $14B $13.3B
 
Long-Term Debt $19.1B $32.3B $28.9B $31.3B $29.1B
Capital Leases -- -- -- -- --
Total Liabilities $34.5B $54.1B $53B $51.9B $47.6B
 
Common Stock $437M $439M $441M $442M $444M
Other Common Equity Adj -$2.8B -$2.3B -$3.1B -$3.2B -$2.7B
Common Equity $34.5B $40.8B $44B $46.7B $49.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $10M $184M $170M $107M $87M
Total Equity $34.5B $41B $44.1B $46.8B $49.7B
 
Total Liabilities and Equity $69.1B $95.1B $97.2B $98.7B $97.3B
Cash and Short Terms $10.3B $4.5B $8.5B $8.1B $5.6B
Total Debt $21.7B $34.9B $34.5B $34.9B $31.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $5.6B $2.8B $3.5B $5.5B $4.1B
Short Term Investments -- -- -- $1.8B $1.8B
Accounts Receivable, Net $5.6B $7.9B $7.9B $7.9B $8.5B
Inventory $4.3B $5.5B $5.7B $5.1B $5.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.4B $1.6B $1.8B $1.9B $2.4B
Total Current Assets $17.7B $18.8B $20.2B $23.6B $23.4B
 
Property Plant And Equipment $6.1B $8.4B $9.4B $9.3B $9.3B
Long-Term Investments -- -- -- -- --
Goodwill $26.8B $41.7B $43.1B $43.8B $46.5B
Other Intangibles $12.8B $19.4B $18B $16B $15.3B
Other Long-Term Assets $2.5B $4.4B $4B $4.2B $4.5B
Total Assets $65.9B $92.7B $94.7B $97.1B $99B
 
Accounts Payable $2.1B $2.7B $2.8B $2.6B $3B
Accrued Expenses $3.4B $4.7B $4.3B $4.3B $4.4B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- -$1M
Total Current Liabilities $7B $12.1B $15.9B $13.9B $13.2B
 
Long-Term Debt $18.6B $31.4B $29.1B $31.2B $31.4B
Capital Leases -- -- -- -- --
Total Liabilities $30.9B $51.6B $52.2B $51.5B $49.6B
 
Common Stock $438M $440M $441M $443M $444M
Other Common Equity Adj -$2.6B -$2.3B -$3.1B -$2.8B -$2.3B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $175M $176M $107M $95M
Total Equity $35.1B $41.1B $42.4B $45.6B $49.5B
 
Total Liabilities and Equity $65.9B $92.7B $94.7B $97.1B $99B
Cash and Short Terms $5.6B $2.8B $3.5B $7.3B $5.9B
Total Debt $18.6B $33.3B $35.3B $35.6B $34.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $6.4B $7.7B $7B $6B $6.3B
Depreciation & Amoritzation $2.3B $2.6B $3.4B $3.4B $3.1B
Stock-Based Compensation $196M $230M $307M $278M $301M
Change in Accounts Receivable -$1.3B -$204M -$430M -$43M -$171M
Change in Inventories -$508M -$1.1B -$825M $598M -$27M
Cash From Operations $8.3B $9.3B $9.2B $8.4B $8.7B
 
Capital Expenditures $1.5B $2.5B $2.2B $1.5B $1.4B
Cash Acquisitions -$38M -$19.4B -$39M -$3.7B -$3.1B
Cash From Investing -$1.5B -$21.9B -$2.2B -$5.1B -$5.8B
 
Dividends Paid (Ex Special Dividend) -$337M -$395M -$455M -$523M -$583M
Special Dividend Paid
Long-Term Debt Issued $3.8B $20.6B $4.7B $7.6B $1.2B
Long-Term Debt Repaid -$1.1B -$11.7B -$4.1B -$7.7B -$3.6B
Repurchase of Common Stock -$1.5B -$2B -$3B -$3B -$4B
Other Financing Activities -$150M $65M -$9M $56M $194M
Cash From Financing $959M $6.6B -$2.8B -$3.6B -$6.8B
 
Beginning Cash (CF) $2.4B $10.3B $4.5B $8.5B $8.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $7.7B -$6B $4.2B -$358M -$4B
Ending Cash (CF) $10.3B $4.5B $8.5B $8.1B $4B
 
Levered Free Cash Flow $6.8B $6.8B $6.9B $6.9B $7.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $2.3B $2.2B $1.3B $1.3B $1.5B
Depreciation & Amoritzation $621M $859M $859M $836M $705M
Stock-Based Compensation $51M $78M $76M $70M $75M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2B $2.2B $729M $1.3B $723M
 
Capital Expenditures $628M $640M $458M $347M $362M
Cash Acquisitions -$1.3B -$40M -$2.7B -- --
Cash From Investing -$2B -$670M -$3.1B -$2B -$527M
 
Dividends Paid (Ex Special Dividend) -$87M -$103M -$117M -$135M -$149M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $626M $1B $1.2B $2.8B
Long-Term Debt Repaid -$2.8B -$1.6B -$523M -- -$838M
Repurchase of Common Stock -$2B -$2B -$3B -$3B -$2B
Other Financing Activities $20M -$34M $20M $109M $45M
Cash From Financing -$4.9B -$3.1B -$2.6B -$1.8B -$102M
 
Beginning Cash (CF) $10.3B $4.5B $8.5B $8.1B $4B
Foreign Exchange Rate Adjustment $137M -$99M -$31M $22M $37M
Additions / Reductions -$4.9B -$1.6B -$5B -$2.6B $95M
Ending Cash (CF) $5.6B $2.8B $3.5B $5.5B $4.2B
 
Levered Free Cash Flow $1.4B $1.6B $271M $904M $361M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $7.9B $7.6B $6B $6B $6.5B
Depreciation & Amoritzation $2.4B $2.8B $3.4B $3.4B $3B
Stock-Based Compensation $201M $257M $305M $272M $306M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $9.9B $9.5B $7.7B $8.9B $8.1B
 
Capital Expenditures $1.8B $2.5B $2.1B $1.4B $1.4B
Cash Acquisitions -$1.4B -$18.1B -$2.7B -$956M -$3.1B
Cash From Investing -$3.2B -$20.6B -$4.6B -$4B -$4.3B
 
Dividends Paid (Ex Special Dividend) -$348M -$411M -$469M -$541M -$597M
Special Dividend Paid
Long-Term Debt Issued $1.3B $21.3B $5.1B $7.7B $2.8B
Long-Term Debt Repaid -$3.6B -$10.6B -$3B -$7.2B -$4.4B
Repurchase of Common Stock -$2B -$2B -$4B -$3B -$3B
Other Financing Activities $164M $11M $45M $145M $130M
Cash From Financing -$4.5B $8.3B -$2.3B -$2.9B -$5.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.2B -$2.8B $792M $2B -$1.3B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $8.1B $7B $5.6B $7.6B $6.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $2.3B $2.2B $1.3B $1.3B $1.5B
Depreciation & Amoritzation $621M $859M $859M $836M $705M
Stock-Based Compensation $51M $78M $76M $70M $75M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2B $2.2B $729M $1.3B $723M
 
Capital Expenditures $628M $640M $458M $347M $362M
Cash Acquisitions -$1.3B -$40M -$2.7B -- --
Cash From Investing -$2B -$670M -$3.1B -$2B -$527M
 
Dividends Paid (Ex Special Dividend) -$87M -$103M -$117M -$135M -$149M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $626M $1B $1.2B $2.8B
Long-Term Debt Repaid -$2.8B -$1.6B -$523M -- -$838M
Repurchase of Common Stock -$2B -$2B -$3B -$3B -$2B
Other Financing Activities $20M -$34M $20M $109M $45M
Cash From Financing -$4.9B -$3.1B -$2.6B -$1.8B -$102M
 
Beginning Cash (CF) $10.3B $4.5B $8.5B $8.1B $4B
Foreign Exchange Rate Adjustment $137M -$99M -$31M $22M $37M
Additions / Reductions -$4.9B -$1.6B -$5B -$2.6B $95M
Ending Cash (CF) $5.6B $2.8B $3.5B $5.5B $4.2B
 
Levered Free Cash Flow $1.4B $1.6B $271M $904M $361M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock